Corinne Bouvier

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 316 citations

Medicine, Oncology, Pharmacology +13

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Gonzague de Pinieux, Marie Karanian, François Le Loarer et al. · PLoS ONE · 2021 · 263 citations · Full text

Veterinary Medicine, Oncology, Pathology +16

MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone

Fanny Dujardin, Matthieu Bui Nguyen Binh, Corinne Bouvier et al. · Modern Pathology · 2011 · 238 citations

Medicine, Oncology, Pathology +17

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 172 citations · Full text

Medicine, Clinical Sciences, Oncology +17

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes et al. · OncoImmunology · 2017 · 170 citations · Full text

Medicine, Immunology, Oncology +17